According to the publisher, the Global OTC Artificial Tears Market is anticipated to attain approximately US$ 6.25 billion by 2030. In today's age, OTC artificial tears are crucial for addressing dry eye syndrome, a common problem due to accelerated display time. These non-prescription eye drops include lubricating substances like saline or glycerin to soothe and moisturize the eyes, relieving dryness, infection, and environmental factors. Conveniently available without a prescription, they briefly relieve people experiencing eye stress, particularly from virtual tool use. With pollutants and air conditioning exacerbating ocular dryness, OTC synthetic tears are essential in maintaining eye health and luxury in present-day lifestyles.
Also, technology has profoundly impacted healthcare, especially within the artificial tears market. In recent years, extensive innovation has been driven by improvements in nanotechnology, biotechnology, and material sciences. These tendencies have revolutionized artificial tear products, critical for dry eye syndrome and ocular issues. Novel formulations incorporating bioengineered components like hyaluronic acid and lipid-based nanocarriers have more suitable efficacy. Furthermore, wearable gadgets and smart technologies have brought about progressive shipping structures, providing personalized and controlled management and enhancing patient compliance and results.
North America leads the global OTC artificial tears market and is expected to maintain its dominance. This is pushed by elements including a growing senior population, government tasks for eye fitness, and an extended focus on eye disease prevention and remedy. Further, the demand for superior healthcare facilities accelerated R&D activities, and the presence of important industry players further fueled market growth. Hence, the Global OTC Artificial Tears Market was worth US$ 4.48 billion in 2023.
2. Ointment
3. Emulsion
4. Gel
5. Spray Solution
6. Suspensions
2. Allergies
3. Infections
4. UV and Blue Light Protection
5. Contact Lens Moisture Retention
6. Others
2. Online Pharmacies
3. Retail Pharmacies
4. Others
1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa
2. Akorn Inc.
3. Alcon
4. Bausch Health Companies Inc.
5. Johnson & Johnson
6. Nicox S.A.
7. Novartis AG
8. Santen Pharmaceutical Co. Ltd.
9. Sun Pharmaceutical Industries Ltd.
Global OTC Artificial Tears Market is predicted to extend at a CAGR of 4.87% between 2024 and 2030
The increasing prevalence of dry eye syndrome, changing lifestyles, rising focus on eye fitness, and growing instances of irreversible vision-threatening problems propel the OTC artificial tears market. According to the NCBI, the worldwide prevalence ranges from 5% to 50%, depending on the geographic region. Furthermore, the increasing senior populace, more vulnerable to eye-related problems, is predicted to power the artificial tears market boom as people search for handy solutions to alleviate signs and maintain eye comfort and health.Also, technology has profoundly impacted healthcare, especially within the artificial tears market. In recent years, extensive innovation has been driven by improvements in nanotechnology, biotechnology, and material sciences. These tendencies have revolutionized artificial tear products, critical for dry eye syndrome and ocular issues. Novel formulations incorporating bioengineered components like hyaluronic acid and lipid-based nanocarriers have more suitable efficacy. Furthermore, wearable gadgets and smart technologies have brought about progressive shipping structures, providing personalized and controlled management and enhancing patient compliance and results.
North America leads the global OTC artificial tears market and is expected to maintain its dominance. This is pushed by elements including a growing senior population, government tasks for eye fitness, and an extended focus on eye disease prevention and remedy. Further, the demand for superior healthcare facilities accelerated R&D activities, and the presence of important industry players further fueled market growth. Hence, the Global OTC Artificial Tears Market was worth US$ 4.48 billion in 2023.
The gel section is among the fast-growing products in the global OTC artificial tears market
The global market for OTC artificial tears is divided into various product types, including solution, ointment, emulsion, gel, spray solution, and suspension. The gel section is one of the products quickly growing within the international OTC artificial tears market. This is due to its more suitable viscosity, which provides extended ocular surface lubrication. This feature offers extended relief for dry eye signs and symptoms, making gel-based artificial tears increasingly popular among consumers looking for robust, long-lasting solutions for ocular pain and dryness.Contact lens moisture retention is possibly rapidly increasing worldwide for over-the-counter artificial tears
The global OTC artificial tears market is segmented by application into different categories, including Allergies, Contact Lens Moisture Retention, Infections, UV and Blue Light Protection, Dry Eye Syndrome, and Others. Contact lens moisture retention may be experiencing a fast boom in the global OTC artificial tears market owing to the growing use of contact lenses worldwide. These eye drops offer necessary lubrication and hydration for contact lens wearers, assuaging discomfort caused by dryness and irritation. As the demand for comfortable and handy contact lens solutions rises, the market for merchandise addressing moisture retention in contact lens wearers expands.Online pharmacies are expected to be one of the fastest-growing channels in the global market for over-the-counter artificial tears
By distribution channel, the global OTC artificial tears market is categorized into Drugstores & Supermarkets, Online Pharmacies, Retail Pharmacies, and Other segments. Online pharmacies are anticipated to earn recognition in the global OTC artificial tears market because of their comfort and accessibility. Consumers can easily purchase artificial tears online, fending off the need for physical visits to brick-and-mortar stores, propelling the increase of online sales channels in this section.Europe could become the second-largest over-the-counter artificial tears market
The global OTC artificial tears market is divided by country into North America (including the United States and Canada), Europe (including France, Germany, Italy, Spain, United Kingdom, Belgium, the Netherlands, and Turkey), Asia Pacific (including China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, and New Zealand), Latin America (including Brazil, Mexico, and Argentina), and Middle East & Africa (including South Africa, Saudi Arabia, and the United Arab Emirates). Europe will potentially emerge as the second-biggest over-the-counter artificial tears market globally, pushed by the growing incidence of age-related ophthalmic issues and dry eye diseases. The aging population and advancing display time, particularly with online classes and work-from-home situations, contribute to diagnoses among more young people. Age-related macular degeneration affects nearly 34 million humans yearly in the European Union and is expected to rise by 25% by 2050. Similarly, diabetic eye sickness cases requiring surgical intervention are predicted to boost the need for artificial tears in postoperative care. Further, institutions of dry eye professionals are providing education and information advancement through diverse structures.Key Players
Leading global OTC artificial tears market businesses include AbbVie Inc., Akorn Inc., Alcon, Bausch Health Companies Inc., Johnson & Johnson, Nicox S.A., Novartis AG, Santen Pharmaceutical Co. Ltd., and Sun Pharmaceutical Industries Ltd.Product Types - Global OTC Artificial Tears Market breakup in 6 viewpoints:
1. Solution2. Ointment
3. Emulsion
4. Gel
5. Spray Solution
6. Suspensions
Application - Global OTC Artificial Tears Market breakup in 6 viewpoints:
1. Dry Eye Syndrome2. Allergies
3. Infections
4. UV and Blue Light Protection
5. Contact Lens Moisture Retention
6. Others
Distribution Channel - Global OTC Artificial Tears Market breakup in 4 viewpoints:
1. Drugstores & Supermarkets2. Online Pharmacies
3. Retail Pharmacies
4. Others
Country - Global OTC Artificial Tears Market of 25 Countries:
1. North America1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa
All the Key players have been covered from 3 Viewpoints:
- Overview
- Recent Development
- Revenue Analysis
Company Analysis:
1. AbbVie Inc.2. Akorn Inc.
3. Alcon
4. Bausch Health Companies Inc.
5. Johnson & Johnson
6. Nicox S.A.
7. Novartis AG
8. Santen Pharmaceutical Co. Ltd.
9. Sun Pharmaceutical Industries Ltd.
Table of Contents
1. Introduction2. Research Methodology3. Executive Summary5. Global OTC Artificial Tear Market
4. Market Dynamics
6. Market Share - Global OTC Artificial Tear Analysis
7. Product Type - Global OTC Artificial Tear Market
8. Application - Global OTC Artificial Tear Market
9. Distribution Channel - Global OTC Artificial Tear Market
10. Country - Global OTC Artificial Tear Market
11. Porter’s Five Analysis - Global OTC Artificial Tear Market
12. SWOT Analysis - Global OTC Artificial Tear Market
13. Key Players
List of Figure
List of Tables
Companies Mentioned
- AbbVie Inc.
- Akorn Inc.
- Alcon
- Bausch Health Companies Inc.
- Johnson & Johnson
- Nicox S.A.
- Novartis AG
- Santen Pharmaceutical Co. Ltd.
- Sun Pharmaceutical Industries Ltd.
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 220 |
| Published | March 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 4.48 Billion |
| Forecasted Market Value ( USD | $ 6.25 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
